Our Services

OBJECTIVE

A leading global central lab provider aimed to identify strategic growth opportunities to exceed the moderate growth targets suggested for the broader central lab market

APPROACH

• Evaluate the market landscape by analyzing each step in the patient and diagnostic journey

• Identify new trends, products, and companies impacting each step in the patient/test journey

• Collaboratively prioritize potential growth opportunities based on synergies with existing business and potential incremental growth

• Develop robust evaluation of a shorter list of potential opportunities and identify client's potential value proposition

• Outline potential incremental revenue potential by implementing ~5 key new initiatives

• Outline strategic imperatives to implement each potential growth opportunity

RESULTS

The client has continued to implement the suggested changes, including organic development of a new product offering for site management organizations and multiple inorganic acquisitions

OBJECTIVE

A large private equity firm aimed to identify areas within the site management space where they could lead consolidation and create a differentiated offering resulting in faster recruitment and shorter trial times

APPROACH

• Evaluate the clinical trial landscape by modality, indication, and site management organization to identify key segments, market size, trends, and competitors

• Conduct targeted market research with key pharma, SMO executives, and regulatory stakeholders to pressure-test trends, unmet needs, and differentiators

• Collaboratively work with the client to identify a target list and initiate partnership discussions

• Outline growth strategy roadmap and key execution steps over a 5-year timeframe

RESULTS

The client used the target list and overarching growth strategy to initiate partnership discussions and start to initiate strategic development of the differentiated clinical trial product offering

OBJECTIVE

A large private pharmaceutical organization aimed to pressure-test the sell-side forecast for a novel formulation of a product used to treat Pulmonary Arterial Hypertension

APPROACH

• Review previous product commercial assessments, including market research and commercial forecast

• Evaluate the market dynamics key to the opportunity, including epidemiology, treated patients, adherence, Tyvaso price and market access, treatment positioning

• Conduct interviews with pulmonologists, cardiologists, and key opinion leaders (KOLs) to understand unmet needs and potential adoption

• Develop a high-level revenue model that independently evaluates the commercial opportunity for the product

• Highlight key variances from the target-provided assumptions and revenue expectations

RESULTS

The client used the evaluation to understand the opportunities and pitfalls associated with the product and to negotiate potential deal terms with the target

OBJECTIVE

A leading developer of digital therapeutics aimed to understand key leverage points within the Major Depressive Disorder patient journey in the United States, Canada, Europe, and Japan

APPROACH (Conducted Sequentially Across Each Geography)

• Evaluate the treatment algorithm and competitive dynamics for both therapeutics and psychotherapy

• Evaluate patient claims data to understand patient progression through the healthcare system, including site of care, physician specialty, and treatment type

• Conduct detailed interviews with physicians, advanced practice providers, nurses and patients to understand nuances associated with the claims data, emotional drivers/barries, and explore potential leverage points

• Synthesize recommendations for leadership to refine clinical development plans to better align with key leverage points across each geography

RESULTS

The client refined the technical components of the digital therapeutic and initiated positioning and messaging research to align with the key leverage points identified

OBJECTIVE

A small pharma company with a topical treatment was interested in understanding the psoriasis patient journey to optimize their physician and patient segmentation

APPROACH

• Track continuously enrolled patients over time to quantify treatment progressions, prescription fill rates, polypharmacy, and prescriber follow-up

• Evaluate the timing of prescription fills to clarify the impact of payer utilization management (i.e., not required to undergo step therapy)

• Assess the timing of prescription fills within lines of therapy to test patient behavior hypotheses

• Conduct claims analysis in parallel with stakeholder research to pair quantitative analyses with behavioral and emotional drivers and treatment progression

• Synthesize insights into a comprehensive patient journey

RESULTS

The client used the robust patient journey analysis to optimize physician and patient targeting strategies